BSD Medical (BSDM $4.42 +0.03) reported third quarter earnings of
($0.03) versus the ($0.04) Capital IQ single Estimate.
Revenue were reported at $1.675 million versus the $0.43 million Capital IQ
Consensus Estimate and $0.124 million last yr (4.39 )
The company said, "We experienced growth in the sale of our hyperthermia systems
during this past quarter, reducing our net loss and our operating cash burn...
We have a strong balance sheet, no debt, and believe we are sufficiently
capitalized to support the global distribution network for our MicroThermX line
of products. We are pleased with the success of the rollout of the MicroThermX,
and are hopeful this is the beginning of a growing sales trend with the
MicroThermX program."






